Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Late Stage Deuteration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel late-stage deuteration route for Lumefantrine-D9 via patent CN111320547B. Cost-effective alternative to di-n-butylamine-D9 for high-purity pharmaceutical intermediate manufacturing.